Archive: 16/11/2016
Controversial drug approval stirs deep concerns—and hope
In September, the Food and Drug Administration approved Exondys, a controversial treatment for Duchenne muscular dystrophy based on tenuous data from just 12 patients. The cover story in Chemical & Engineering News (C&EN), ...
Nov 16, 2016
UK study to help chronic pain sufferers back to work
Researchers from the University of Warwick's Medical School are leading a novel study to explore ways of helping people with chronic pain back to work.
Nov 16, 2016